Diabetes Care Devices Market Trends Report & Growth Forecast 2028
[研究报告] 糖尿病护理设备市场预计将从 2022 年的 289.421 亿美元增长到 2028 年的 421.193 亿美元;预计 2022 年至 2028 年的复合年增长率为 4.8%。CAGR of 4.8% from 2022 to 2028.
市场洞察和分析师观点:
糖尿病护理设备是用于监测糖尿病患者血糖水平的医疗设备。监测设备被称为连续血糖监测设备或血糖仪。其他糖尿病护理设备用于向体内输送胰岛素,这些设备由无法自行产生胰岛素的糖尿病患者使用。胰岛素输送设备包括胰岛素泵、胰岛素笔、胰岛素注射器等。技术进步的增加、肥胖发病率的上升、胰岛素输送设备的采用率的提高以及糖尿病患病率的上升正在推动糖尿病护理设备市场的增长。主要制造商正专注于技术创新和先进产品的开发,以获得相当大的市场份额。例如,2023 年 4 月,美敦力公司获得了美国食品药品监督管理局 (FDA) 对其 MiniMed 780G 系统的批准。该系统具有市场上所有自动胰岛素泵中最低的血糖目标设置(低至 100 mg/dL),并且更接近地反映了非糖尿病患者的平均血糖。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
糖尿病护理设备市场:
复合年增长率(2022 - 2028)4.8%- 2022 年市场规模
289.4 亿美元 - 2028 年市场规模
421.2 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 屋宇署
- 诺和诺德公司
- B. Braun Melsungen AG
- 美敦力
- Tandem 糖尿病护理公司
- 胰岛素公司
- 礼来公司
- DEXCOM 公司
- 泰尔茂株式会社
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 血糖监测设备和胰岛素输送设备
- 家庭护理、医院和诊所
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
增长动力和机遇:
糖尿病是一种致命的慢性疾病,没有专门的治疗方法。它主要是由于人体无法产生或有效利用胰岛素而引起的。这种无能使人体无法充分调节血糖水平。糖尿病有两种形式——I 型糖尿病或尿崩症和 2 型糖尿病或糖尿病。全球糖尿病的发病率正在稳步上升。2 型糖尿病是最常见的糖尿病类型,随着文化和社会的变化而增加。在高收入国家,约 91% 的成年人患有 2 型糖尿病。根据国际糖尿病联合会 (IDF) 的数据,2021 年糖尿病将影响约 5.37 亿 20-79 岁人群。同样,到 2030 年,糖尿病患者总数预计将激增至 6.43 亿,到 2045 年将激增至 7.83 亿。
2021 年 vs 2030 年 vs 2045 年全球 20-79 岁人群糖尿病患病率(单位:百万)
地区 | 2021 | 2030 | 2045 |
北美和加勒比地区 | 51 | 57 | 63 |
南美洲和中美洲 | 三十二 | 40 | 49 |
非洲 | 24 | 33 | 55 |
欧洲 | 61 | 67 | 69 |
中东和北非 | 73 | 95 | 136 |
东南亚 | 90 | 113 | 152 |
西太平洋 | 206 | 238 | 260 |
来源:国际糖尿病联合会 (2022)
糖尿病会导致身体各部位出现多种并发症,并增加过早死亡的总体风险。心脏病发作、中风、肾衰竭、截肢、视力丧失和神经损伤是与糖尿病相关的几种主要并发症。因此,患有这种疾病的患者需要频繁监测和外部注射胰岛素。在预测期内,糖尿病的患病率不断上升,推动了全球糖尿病护理设备市场的增长。
报告细分和范围:
“全球糖尿病护理设备市场”根据产品、最终用户和地理位置进行细分。根据产品,糖尿病护理设备市场细分为血糖监测设备和胰岛素输送设备。根据最终用户,糖尿病护理设备市场细分为家庭护理和医院及诊所。根据地理位置,糖尿病护理设备市场细分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)
节段分析:
全球糖尿病护理设备市场根据产品细分为血糖监测设备和胰岛素输送设备。2022 年,按产品划分,血糖监测设备部分占据最大的市场份额。此外,糖尿病护理设备市场中的血糖监测设备部分预计在 2022 年至 2028 年期间的需求也将以 5.0% 的最快复合年增长率增长。血糖监测设备市场由血糖仪、刺血针、测试条和其他血糖监测设备等组件组成。2022 年,测试条部分在血糖监测设备部分中占据最大的市场份额。血糖监测设备或血糖仪是医疗设备,用于确定糖尿病患者血液中葡萄糖的大致水平或浓度。可以通过各种方式测量血糖浓度,例如通过测试条、刺血针等。
全球糖尿病护理设备市场,终端用户细分为家庭护理和医院及诊所。2022 年,按终端用户计算,家庭护理部门占据最大的市场份额。此外,由于糖尿病患病率上升,该部门预计未来几年也将以最快的速度增长,并使患者能够独立管理和监测他们的糖尿病。医院是一个多方面的组织,是一个通过并发症为人们提供健康的机构,然而,专门的治疗是通过科学设备提供的。受过现代医学科学问题教育的训练有素的员工团队协助提供更好的治疗。他们都为恢复和保持健康的共同目标而协调一致。医院通过为患有各种疾病的患者群体提供广泛的医疗服务发挥着重要作用。
区域分析:
根据地理位置,糖尿病护理设备市场分为五个主要区域:北美、欧洲、亚太地区、南美和中美以及中东和非洲。2020 年,美国占据北美糖尿病护理设备市场的最大份额。预计糖尿病护理设备市场的增长将在美国占据更大的份额。在美国,糖尿病护理是最常见和最昂贵的慢性病之一。老年人群中糖尿病的发病率最高。然而,糖尿病的患病率在美国持续上升,除了老年人口之外,超重和肥胖人群中也普遍存在糖尿病。根据国际糖尿病联合会 (IDF) 的数据,2021 年,糖尿病将影响全美约 3220 万名 20 至 79 岁的人。同样,到 2030 年,糖尿病患者总数预计将激增至 3470 万,到 2045 年将激增至 3620 万。该国正在投入巨额资金,但在预期寿命、婴儿死亡率和其他相关疾病方面,该国仍落后于其他发达国家。尽管如此,该国在糖尿病护理方面表现良好,在其他 11 个主要发达国家中排名第四。尽管糖尿病患病率不断上升,但仍需要加强糖尿病护理系统。
亚太地区糖尿病护理设备市场分析基于中国、日本、印度、澳大利亚、韩国和亚太地区其他地区这五个主要国家。然而,预计亚太地区在预测期内的复合年增长率最高。该地区的糖尿病护理设备市场主要由中国、日本和印度等国家占据。市场的增长主要由中国贡献,增长归因于糖尿病护理产品的最大产量和通过最广泛的电子商务链提供产品。中国的糖尿病患病率明显较高,过去几十年来,该国 2 型糖尿病的发病率迅速上升。2 型糖尿病已成为该国的主要问题,因为它在低年龄组人群中更为常见。导致 2 型糖尿病增长的主要原因是遗传和环境因素。
糖尿病患病率的上升是推动市场增长的重要因素。世界上人口最多的国家糖尿病患者数量是全球最多的国家——2019 年约为 1.16 亿。到 2045 年,这一数字预计将达到 1.47 亿。此外,由于中国约 95% 的糖尿病患者患有 2 型糖尿病,中国糖尿病患病率的快速上升可能归因于超重和肥胖率的上升以及身体活动减少,而这是经济发展、生活方式改变和饮食习惯所致。
行业发展和未来机遇:
在全球糖尿病护理设备市场中运作的主要参与者采取的各种举措如下:
- 2023 年 4 月,美敦力公司获得美国食品药品监督管理局 (FDA) 批准其 MiniMed 780G 系统,该系统配备 Guardian 4 传感器,采用 SmartGuard 技术时无需进行指尖采血。
- 2022年4月,全球领先的医疗技术公司BD(Becton, Dickinson and Company)宣布已完成对Embecta Corp.(embecta)的分拆,该公司持有BD之前的糖尿病护理业务,现已成为全球最大的纯糖尿病管理公司之一。
- 2022 年 3 月,医疗技术领域的全球领导者美敦力公司 (Medtronic plc) 宣布,一项关键的糖尿病技术——持续血糖监测 (CGM) 的报销已在北美和南美的多个国家扩展或启动。CGM 系统提供有关血糖水平的关键信息,有助于简化糖尿病管理。自动胰岛素泵系统报销在欧洲也取得了进展。
- 2022 年 1 月,印度制药公司 Novo Nordisk India 在印度推出了首款糖尿病治疗药物。该公司推出了世界上第一个也是唯一一个口服索马鲁肽,这是糖尿病管理领域的革命性药物
- 2022 年 3 月,医疗技术领域的全球领导者 Terumo Corporation 与数据管理、远程患者监控和慢性病患者移动应用领域的全球领导者 Glooko 宣布了一项技术整合,旨在在全球范围内共同提供新的糖尿病数据共享解决方案。这项新的整合将使糖尿病患者能够将 MEDISAFE WITHTM 胰岛素贴片泵的记录数据传输到 Glooko 平台,从而帮助他们更轻松地以图表形式直观地了解胰岛素剂量、食物和活动,并更有效地实现个性化的远程患者监控和患者护理。
糖尿病护理设备市场报告范围
报告属性 | 细节 |
---|---|
2022年的市场规模 | 289.4亿美元 |
2028 年市场规模 | 421.2亿美元 |
全球复合年增长率(2022 - 2028) | 4.8% |
历史数据 | 2020-2021 |
预测期 | 2023-2028 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
Covid-19的影响:
COVID-19 疫情影响了全球各国的经济和行业。北美、欧洲、亚太地区 (APAC)、南美和中美 (SAM) 以及中东和非洲 (MEA) 的封锁、旅行限制和企业关闭阻碍了多个行业的增长,包括医疗保健行业。因此,医疗保健系统负担过重,向所有患者提供医疗服务已成为该地区的一项挑战。此外,医疗器械行业也面临着这一疫情的负面影响。随着 COVID-19 疫情的持续蔓延,医疗器械公司在管理运营方面遇到了困难。许多提供糖尿病护理设备的公司在美国开展业务,而 COVID-19 疫情的广泛爆发对其业务产生了不利影响。这扰乱并限制了公司分销产品的能力,并导致公司设施暂时关闭。然而,随着 COVID-19 康复率的提高,医院已逐渐开始恢复选择性手术,预计对糖尿病护理等医疗设备的需求将会增加。
竞争格局和重点公司:
全球糖尿病护理设备市场的一些知名参与者包括 BD;Novo Nordisk A/S;Medtronic;B. Braun Melsungen AG;Tandem Diabetes Care Inc.;Insulet Corporation;Eli Lilly and Company;Dexcom, Inc.;Terumo Corporation;F. Hoffmann-LA Roche LTD 等。这些糖尿病设备公司专注于新产品的推出和地域扩张,以满足全球不断增长的消费者需求并增加其专业产品组合的范围。他们在全球拥有广泛的影响力,这使他们能够服务于大量客户,从而增加他们的市场份额。该报告提供了糖尿病护理设备市场的趋势分析,强调了各种参数,例如技术进步、市场动态和全球主要市场参与者的竞争格局分析。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global diabetes care devices market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The largest market for diabetes care devices is held by the North American region. The United States held the largest market for diabetes care devices. The Asia-Pacific region is expected to be the fastest-growing region during the forecast period.
The homecare segment are expected to be the leading end user segment in the diabetes care devices market in 2021.
The glucose monitoring devices segment is expected to be the leading type segment in the diabetes care devices market in 2021.
The diabetes care devices market majorly consists of the players such as BD; Novo Nordisk A/S; B. Braun Melsungen AG; Medtronic; Tandem Diabetes Care Inc.; Insulet Corporation; Eli Lilly and Company; DEXCOM, INC.; Terumo Corporation; F. HOFFMANN-LA ROCHE LTD.; among others.
The diabetes care devices are the medical devices used to monitor the glucose levels in the blood of diabetic patients. The monitoring devices are known as continuous glucose monitoring devices or glucometers. Insulin delivery devices are used to deliver insulin in the body, these devices are used by the diabetes patients who are unable to produce insulin by their own. These devices include pens, pumps, syringes and others.
The List of Companies - Diabetes Care Devices Market
- BD
- Novo Nordisk A/S
- B. Braun Melsungen AG
- Medtronic
- Tandem Diabetes Care Inc.
- Insulet Corporation
- Eli Lilly and Company
- DEXCOM, INC.
- Terumo Corporation
- F. HOFFMANN-LA ROCHE LTD.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.